Identifying therapeutic targets in gastric cancer: the current status and future direction
| dc.contributor.author | Yu, Beiqin | |
| dc.contributor.author | Xie, Jingwu | |
| dc.contributor.department | Department of Pediatrics, IU School of Medicine | en_US |
| dc.date.accessioned | 2017-05-02T18:22:06Z | |
| dc.date.available | 2017-05-02T18:22:06Z | |
| dc.date.issued | 2016-01 | |
| dc.description.abstract | Gastric cancer is the third leading cause of cancer-related death worldwide. Our basic understanding of gastric cancer biology falls behind that of many other cancer types. Current standard treatment options for gastric cancer have not changed for the last 20 years. Thus, there is an urgent need to establish novel strategies to treat this deadly cancer. Successful clinical trials with Gleevec in CML and gastrointestinal stromal tumors have set up an example for targeted therapy of cancer. In this review, we will summarize major progress in classification, therapeutic options of gastric cancer. We will also discuss molecular mechanisms for drug resistance in gastric cancer. In addition, we will attempt to propose potential future directions in gastric cancer biology and drug targets. | en_US |
| dc.identifier.citation | Yu, B., & Xie, J. (2016). Identifying therapeutic targets in gastric cancer: the current status and future direction. Acta Biochimica et Biophysica Sinica, 48(1), 90–96. http://doi.org/10.1093/abbs/gmv084 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/12419 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Oxford University Press | en_US |
| dc.relation.isversionof | 10.1093/abbs/gmv084 | en_US |
| dc.relation.journal | Acta Biochimica et Biophysica Sinica | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | PMC | en_US |
| dc.subject | Gastric cancer | en_US |
| dc.subject | Targeted therapy | en_US |
| dc.subject | Cancer stem cell | en_US |
| dc.subject | Wnt | en_US |
| dc.subject | Hedgehog | en_US |
| dc.title | Identifying therapeutic targets in gastric cancer: the current status and future direction | en_US |
| dc.type | Article | en_US |
| ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689156/ | en_US |